Integrated Life Systems (ILS)

ILS develops diagnostic and bioprocessing platforms that deliver qualitative and quantitative breakthroughs across R&D, clinical, biotech, and industrial workflows.

Technologies engineered for diagnostic, clinical, biotech, and industrial applications: Non-invasive measurements, DDLS spectroscopy, the Lysor® plate-wave ultrasonic lysis, breakthrough in R&D and bioprocessing-scale, skin cooling — including needle‑free, reagentless glucose detection.

Advanced Life‑Sciences Platforms

Built on Physical Sciences

Discover ILS

  • Physical Sciences‑Driven Platforms
    ILS relies on modal analysis, DDLS spectroscopy, and proprietary sample-processing physics rather than incremental biochemistry.

  • Commercial‑Ready IP
    Patented systems engineered for OEM integration, licensing, and rapid deployment.

  • Proven Expertise & Execution: Founded by veterans of Abbott Laboratories, Baxter International, Monsanto, Nanosphere, and Siemens — with a combined track record of over 20 startups, multiple issued patents, and technologies successfully commercialized and licensed.

  • High‑Sensitivity, Non‑Invasive Detection
    Modal‑analysis and DDLS systems capture structural and molecular changes conventional optics miss.

  • Fast Integration Pathways
    Modular architectures designed to drop into existing clinical, industrial, and research workflows.

  • Broad Application Reach
    Diagnostics, bioprocess monitoring, industrial sensing, and custom OEM solutions.

Technologies Created by ILS - Available for Licensing & Partnership

ILS Technologies

Available for Licensing & Partnership

Why ILS